GOOG vs MRK: Which Is the Better Buy?
Side-by-side comparison of Alphabet Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-18.
Alphabet Inc. · Communication Services
$339.40
-4.4% upside to fair value
Grade D
High Quality
VS
Merck & Co., Inc. · Healthcare
$121.42
-2.9% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
MRK has more upside to fair value
(-2.9%).
MRK trades at a lower forward P/E
(14.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GOOG |
MRK |
| Current Price |
$339.40 |
$121.42 |
| Fair Value Estimate |
$324.34 |
$118.00 |
| Upside to Fair Value |
-4.4%
|
-2.9%
|
| Market Cap |
$4,105.7B |
$300.2B |
| Forward P/E |
31.2x
|
14.0x
|
| EV / EBITDA |
23.1x
|
11.8x
|
| Price / Sales |
10.3x
|
4.1x
|
| Price / FCF |
56.4x
|
21.4x
|
| Revenue Growth YoY |
+11.3%
|
+1.3%
|
| Gross Margin |
59.7%
|
81.5%
|
| Operating Margin |
32.0%
|
41.2%
|
| Return on Equity |
35.0%
|
34.7%
|
| Dividend Yield |
0% |
3.1% |
| FCF Yield |
1.77%
|
4.7%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Alphabet Inc. operates as a global leader in internet content, advertising, cloud computing, and AI technologies, with dominant market positions in search, browser, and mobile operating systems. The company benefits from a high-quality business model characterized by a durable competitive moat, strong revenue growth of 11.3% year-over-year, and robust profitability with net margins of 32.8%. Desp…
Merck is a top-5 global pharmaceutical company generating $65B in annual revenue with 81.5% gross margins and 28% net margins. Keytruda, the world's best-selling drug at $31.7B (49% of pharma revenue), faces patent expiry in 2028. Merck is aggressively building replacements through M&A and pipeline launches: Winrevair ($1.4B year one), Capvaxive ($759M), and the $6.7B Terns acquisition for TERN-7…
Accumulation Zones
| Metric |
GOOG |
MRK |
| Zone Low |
$243.25 |
$88.00 |
| Zone High |
$275.69 |
$100.00 |
| In Buy Zone? |
No
|
No
|